A Core Facility for Early-Stage Biotherapy Development. We provide state-of-the-art solutions for next-generation therapeutic research, including Biologics, Cell, Gene and RNA therapies.

The Aim

CONCEPT: Bridging the gap in biologics and advanced therapy research infrastructure. We address the need for access to next-generation instrumentation and expertise for rapid generation of optimised cell lines and biological material, accelerating biologics and advanced therapy research.



You present your CONCEPT: a gene identifier or candidate sequence.


Our lead team evaluates your requirements and prepares an experimental plan.


We design, generate, and process your sequences through our quality-controlled workflows.

Read more


You receive a physical Biotherapy product or optimised cell line producing the product of interest, to further your research.

Read more

We are flexible

Flexible and Affordable Access 

  • We offer access to individual instruments, or end-to-end workflows, depending on your requirements. 
  • CONCEPT is priced with affordability in mind. Separate access charges streams have been developed for academic and industry partners. 


CONCEPT forms part of the new Cell and Gene Therapy building at NIBRT, a world-class institute that provides innovative training and research solutions for the biopharmaceutical industry. NIBRT offers a unique learning experience in a contemporary facility that replicates the most modern industrial bioprocessing plant. NIBRT also performs cutting-edge research in collaboration with industry and academic partners. NIBRT’s mission, with support from IDA Ireland, is to help the growth and development of the biopharmaceutical industry in Ireland and internationally.